Impact of hypoalbuminemia on ceftriaxone treatment failure in patients with Enterobacterales bacteremia: a propensity matched, retrospective cohort study
✅ Just Accepted
🔓 Open Access
🔗 https://t.co/b5Bf41WXMH
📣New in @OFIDJournal: Hypoalbuminemia was not significantly associated with treatment failure in patients with Enterobacterales bacteremia receiving CRO, though numerically higher failure especially in the ICU population were noted: https://t.co/0zbS3EnVbC #IDtwitter#TwitteRx
🆕️⚡️⚡️Propensity matched, retrospective cohort study by @Evan_Steere@OFIDJournal
Patients with hypoalbuminemia experienced numerically higher rates of treatment failure, although did not reach statistical significance
#IDTwitter https://t.co/YFCLmXGQL7
Wondering if anyone could help shed some light on what the mechanism of resistance is for this Proteus? See this resistance pattern pretty regularly from our Proteus. #IDtwitter
Ceftriaxone for 6 weeks used for penicillin-susceptible organisms makes my heart break just a little bit. The soft screams of countless billions of unnecessarily killed bacteria continues to haunt me in the night.
Confused by someone labeled "immunocompromised" and their infection risks? Same. So with guidance of our ID Mentors @PrathitKulkarni, @Cortes_Penfield, & @transplantID - @KatieBedardMD, Charmaine Mutucumarana and I created an Infections in Immunocompromised Hosts Schema
It's Rare!
NEW 🔥🔥@CDCMMWR
During December 14–23, 2020, VAERS detected 21 cases of anaphylaxis after administration of 1,893,360 first doses of the Pfizer-BioNTech COVID-19 vaccine(11.1 cases per million doses); 71% of these occurred within 15 minutes https://t.co/hxS1hhkQuG
Excited to finally get to share this work with colleagues - Remdesivir for Severe COVID-19 versus a Cohort Receiving Standard of Care https://t.co/QRVUJ7bRhD @MethodistHosp @drgrimey @DirkSostman
NEW #CID Infectious Diseases Society of America Position Paper: Recommended Revisions to the National Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) Sepsis Quality Measure https://t.co/wwElq1r0oB
Attn Texas peeps: My ASP partner #twitterlessScott called the BOP to clarify which diagnoses count as having "evidence for use" to allow fills of HCQ and azithro. Was told that only labeled/FDA-approved indications count.
NEW 🔥⚡Retrospective multicenter cohort study @JAMA_current
Empirical Anti-MRSA vs Standard Antibiotic Therapy and Risk of 30-Day Mortality in Patients Hospitalized for Pneumonia. #IDTwitter#medtwitter
https://t.co/X0jWhMaUMT
Come by and check out @MethodistHosp posters at IDWeek! Poster 1038: Impact of an Electronic Antibiotic Timeout on the Utilization of Frequently Prescribed Antibiotics in Hospitalized Patients @tydrake5@rxchuckles @TravicayPharmD @GareyKgarey@LogansRunRx@SIDPharm @IDWeek2019
Come by and check out @MethodistHosp posters at IDWeek! Poster number 1095: Prevalence and Characteristics of Self-Reported Antibiotic Allergies across a Multi-Hospital Healthcare System @tydrake5@SIDPharm @IDWeek2019 @HMASP